IMVU:LSE:LSE-iShares Edge MSCI Europe Minimum Volatility UCITS ETF EUR (Acc) USD (USD)

ETF | Others |

Last Closing

USD 63.025

Change

-0.17 (-0.26)%

Market Cap

USD 0.72B

Volume

283.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

N/A

USD 292,109.19B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 608.02B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 608.02B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

N/A

USD 321.87B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
0QZO:LSE 0QZO

N/A

USD 258.54B

ETFs Containing IMVU:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.98% 49% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.98% 48% F 54% F
Trailing 12 Months  
Capital Gain 7.78% 45% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.78% 43% F 52% F
Trailing 5 Years  
Capital Gain 22.77% 47% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.77% 45% F 56% F
Average Annual (5 Year Horizon)  
Capital Gain 5.24% 54% F 59% D-
Dividend Return 5.24% 54% F 59% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.85% 50% F 67% D+
Risk Adjusted Return 37.81% 58% F 69% C-
Market Capitalization 0.72B 75% C 57% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike